Loading...
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study
BACKGROUND: Understanding the impact of the tumor immune microenvironment and BRCA1/2-related DNA repair deficiencies on the clinical activity of immune checkpoint inhibitors may help optimize both patient and treatment selection in metastatic triple-negative breast cancer. In this substudy from the...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Format: | Online Artículo Texto |
Sprog: | English |
Udgivet: |
Oxford University Press
2021
|
Fag: | |
Online adgang: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328980/ https://www.ncbi.nlm.nih.gov/pubmed/33523233 http://dx.doi.org/10.1093/jnci/djab004 |